Amino acid peritoneal dialysis fluid for dogs and cats and preparation method thereof

Abstract

The invention discloses an amino acid peritoneal dialysis solution for dogs and cats and a preparation method thereof, and belongs to the fields of animal husbandry, veterinarian and breeding industry. The peritoneal dialysis solution is composed of the following components by weight (for each 1000 mL): 1.0 to 2.0 grams of L-arginine, 1.0 to 1.6 grams of L-histidine, 0.6 to 0.9 gram of L-isoleucine, 1.3 to 1.5 grams of L-leucine, 0.8 to 1.0 gram of L-lysine, 0.4 to 0.6 gram of L-methionine, 0.7 to 0.8 gram of L-phenylalanine, 0.4 to 0.6 gram of L-threonine, 0.2 to 0.4 gram of L-tryptophan, 0.8 to 1.2 grams of L-valine, 0.1 to 0.3 gram of taurine, 0.2 to 0.3 gram of vitamin B6, 0.1 to 0.3 gram of astragalus polysaccharide, 0.1 to 0.3 gram of calcium chloride, and the balance being water for injection. The provided amino acid peritoneal dialysis solution can well relieve symptoms caused by kidney failure such as hyperitremia, hyperphosphatemia, hypoproteinemia, and the like, and can improve the ultrafiltration function of peritoneum and substance clearance rate.

Description

technical field [0001] The invention belongs to the field of animal husbandry and veterinary breeding, and particularly relates to an amino acid peritoneal dialysis solution for treating renal failure in dogs and cats. Background technique [0002] Renal failure is based on the occurrence of various kidney diseases. Due to the gradual damage of nephrons, the slow development of renal function decline leads to irreversible renal failure. The disease mainly manifests as decreased renal function, stagnation of metabolic waste (especially nitrogen-containing metabolites after protein decomposition), water, electrolyte and acid-base balance disorders, and various endocrine dysfunctions related to the kidneys, so that it cannot maintain A clinical syndrome caused by the stability of the internal environment of the body. In recent years, the problem of renal failure in dogs and cats has attracted more and more attention, and it is imperative to study new methods for effective trea...

AI Technical Summary

Problems solved by technology

At present, the peritoneal dialysis solution of dogs and cats generally uses the dialysis solution used by humans with glucose as the main osmotic agent. Because of its high sugar, hypertonicity, low pH value and the production of glucose degradation products, it will cause changes in the structure and function of the peritoneum, and eventually It can lead to peritoneal fibrosis and peritoneal ultrafiltration failure. In addition, it can also cause accompanying diseases such as hypoproteinemia, hyperlipidemia, and hyperinsulinemia in dogs and cats, which seriously affects the quality of life of pet dogs and increases the number of dog owners. financial burden and emotional distress

Images